Manipal Health Enterprises Share News - Latest Updates, Live News & More

Latest news about Manipal Health Enterprises

Manipal Health shares worth ₹26.80 crore change hands in large trade Oct 06, 2026

A large-trade signal flagged approximately 399,997 shares of Manipal Health Enterprises on BSE. Shares changed hands at ₹670.00, with a combined value of ₹26.80 crore. This is a real-time trade-scanning signal and not a confirmed exchange-reported event. Official large-trade disclosures by NSE/BSE are published only after market close.

Manipal Health AGM passes 10 of 11 resolutions; upside deal fails Oct 01, 2026

Manipal Health redeems ₹5,310 crore NCDs using IPO proceeds Sep 19, 2026

Manipal Health Enterprises schedules 16th AGM for September 29 Sep 05, 2026

Manipal Health Enterprises discloses encumbrance covenants on promoter shares Sep 04, 2026

More news about Manipal Health Enterprises

28Aug 26

Manipal Health co-CEO targets volume growth, capacity expansion, and deleveraging

Manipal Health Enterprises co-CEO outlines strategy for volume-led growth. Focus includes enhancing operational and infrastructure capacity. Deleveraging the balance sheet remains a key priority.

27Aug 26

Manipal Health Enterprises releases Q1FY27 earnings call transcript

Revenue grew 38% YoY to ₹3,091 crore driven by volume-led expansion. Network EBITDA rose 26% to ₹749 crore with 24.2% operating margin. Sahyadri Hospitals reported 13% revenue growth and improved efficiency. Company launched 50th hospital in Bangalore and acquired Kinder Hospital. Digital revenue contributed 23% of total income at ₹710 crore.

21Aug 26

Manipal Health board approves Q1FY27 unaudited standalone, consolidated results

Revenue grew 38.1% YoY to ₹3,091 crore in Q1FY27. Board approved unaudited standalone and consolidated results on August 20, 2026. Adjusted PAT grew 30.9% YoY after excluding acquisition-related interest costs. Occupancy rates improved by 290 bps to 65.0%. CONGO-R specialty gross inpatient revenue grew 45% YoY.

10Aug 26

Manipal Health Enterprises pledges 6.31 crore shares to secure NCDs

Manipal Health Enterprises Limited disclosed a pledge of 6.31 crore shares by promoter entities MEMG India and MEMGIPL to secure INR 9,420 crore in NCDs. The encumbrance affects 4.80% of total share capital, with an additional 23.26% subject to covenants, bringing total encumbered shares to 28.06%. Vistra ITCL serves as the common security trustee.

10Aug 26

Manipal Health Enterprises promoters encumber 21.78% stake for term loan

Deutsche Bank AG disclosed that 286,443,818 shares of Manipal Health Enterprises Limited, held by promoter entities Manipal Global Health Services, Cypress Holdings, and MRMSI, have been encumbered. This represents 21.78% of the issued capital and 21.50% on a diluted basis. The encumbrance serves as security for a term loan facility, involving indirect charges created by parent companies MEMG International Ltd and Manipal Global Health Services in May and July 2025.

10Aug 26

Manipal Health Enterprises discloses 8.86% stake encumbrance

Manipal Health Enterprises Limited disclosed an encumbrance over 116.6 million shares (8.86% stake) via non-disposal undertaking. Axis Trustee Services Limited acts as onshore security agent for a term loan facility secured by Manipal Global Health Services and Cypress Holdings. The shares are held in trust for lenders but carry no beneficial interest for the agent.

06Aug 26

Manipal Health Enterprises appoints Sathish K R as Compliance Officer

Manipal Health Enterprises Limited has confirmed Sathish K R as its Compliance Officer since November 25, 2025. The disclosure, filed on August 5, 2026, aligns with SEBI LODR Regulations and highlights his dual role as Company Secretary and General Counsel, ensuring robust governance continuity.

05Aug 26

Manipal Health Enterprises authorizes KMPs to decide materiality

Manipal Health Enterprises Limited has empowered its Key Managerial Personnel, including MD Dilip Jose and CFO Sameer Agarwal, to determine the materiality of events for regulatory disclosures. This authorization under SEBI Listing Regulations aims to streamline compliance and ensure timely investor communication. The details were filed with BSE and NSE on August 5, 2026.

05Aug 26

Manipal Health confirms KFin as Registrar and Share Transfer Agent

Manipal Health Enterprises Limited appointed KFin Technologies Limited as its Registrar and Share Transfer Agent effective February 13, 2025. The move complies with SEBI LODR Regulation 7(1). The filing was submitted on August 5, 2026.

05Aug 26

Manipal Health Enterprises adopts SEBI fair disclosure code for UPSI

Manipal Health Enterprises Limited has implemented a comprehensive Code of Practices for fair disclosure of Unpublished Price Sensitive Information under SEBI PIT Regulations. The framework assigns responsibilities to the CIRO and Compliance Officer to ensure prompt, uniform dissemination of material data. It includes strict protocols for analyst interactions, handling market rumors, and sharing information for legitimate business purposes, with a mandatory eight-year digital record retention. The policy takes effect upon Board approval of the Draft Red Herring Prospectus.

Manipal Health Enterprises

627.70

-2.35

(-0.37%)

1 Year Returns:+6.39%

Get More Market Insights with

Stock Rental via SLBM

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357 Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104